eye problems with semaglutide A new study suggests patients taking — the active ingredient in Ozempic and Wegovy — may be at higher risk of developing an condition that can cause blindness. Non-arteritic anterior A potentially blinding condition is

10.1016/0014-4800(71)90056-6 Exp

Unreconstituted lyophilised LIPO-C powder remains stable at 20C for months, but once mixed, the amino acids methionine, inositol, and choline begin oxidising at room temperature

119 CRM hydroxycitrate has been found to stimulate autophagy in U2OS osteosarcoma cells in vitro, thereby increasing antitumor immunosurveillance and reducing tumor mass in mice with autophagy-competent mutant KRAS-induced lung cancers

In such cases, the surgeon might recommend an anal sphincterotomy

STAT News, March 2026 254M Indians with generalised obesity ICMR-INDIAB 17 43.3% Metabolically obese at normal BMI ICMR-INDIAB 23 BMI 23 WHO Asia-Pacific overweight threshold for South Asians WHO Asia Pacific Guidelines CLINICAL TRANSPARENCY GLP-1 therapy is clinically proven and well-tolerated by most patients

While no protein shake is specifically formulated for semaglutide users, certain products align well with the clinical considerations outlined above